Evolución de sunitinib en 1ª línea en CCRm: Esquemas alternativos - page 14

Esquema 2/1:

Farmacocinética

Día 42: Tras 2 semanas descanso en

ciclos 4/2

Bjarnason GA et al .Urologic oncology.2014

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,4,5,6,7,8,9,10,11,12,13 15,16,17,18,19,20,21,22,23,24,...43